Biotech Values

[DewDiligence]

ALUR +145% on muscle-mass PR:

https://finance.yahoo.com/news/allurion-announces-publication-data-demonstrating-120000975.html

Allurion Technologies, Inc., a company dedicated to ending obesity, today announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at four months on the Allurion Program.

…In the study, 571 patients across three obesity centers treated with the Allurion Program reduced their weight on average by 13.9kg from 97.9kg to 84.0kg in just four months. Over that same period, lean mass—which includes muscle mass—increased by 2.8kg on average from 49.8kg to 52.6kg.

…All patients experienced significant reductions in body fat percentage, decreasing from 32.7% to 27.9% in just 4 months.

Caveat emptor! The centerpiece of the Allurion Program is an ingested gastric balloon to reduce appetite that is (purportedly) excreted naturally after four months.

This is the paper referenced in the above PR:
https://www.mdpi.com/2039-7283/14/3/61

ALUR went public in Aug 2023 via a SPAC merger (https://investors.allurion.com/news/news-details/2023/Allurion-Debuts-as-a-Publicly-Traded-Company-on-the-NYSE/default.aspx ).